Medivation's (MDVN) Talazoparib Acquisition is 'Good Use of Cash' - Maxim (BMRN)
Go back to Medivation's (MDVN) Talazoparib Acquisition is 'Good Use of Cash' - Maxim (BMRN)| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 66.53 +0.10 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.43 | 52 Week High | $108.96 | |||
| Open | $65.79 | 52 Week Low | $62.12 | |||
| Day High | $66.64 | P/E | N/A | |||
| Day Low | $65.52 | EPS | $-1.27 | |||
| Volume | 2,299,209 | |||||
| Medivation, Inc. (NASDAQ: MDVN) | Delayed: 81.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.44 | 52 Week High | $81.48 | |||
| Open | $3852.47 | 52 Week Low | $26.41 | |||
| Day High | $81.44 | P/E | N/A | |||
| Day Low | $81.44 | EPS | $-1.03 | |||
| Volume | 13,593 | |||||
